Teladoc Health EBITDA 2014-2024 | TDOC

Teladoc Health ebitda from 2014 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Teladoc Health Annual EBITDA
(Millions of US $)
2023 $106
2022 $24
2021 $15
2020 $-383
2019 $-10
2018 $-16
2017 $-36
2016 $-46
2015 $-50
2014 $-13
2013 $-5
Teladoc Health Quarterly EBITDA
(Millions of US $)
2024-09-30 $47
2024-06-30 $48
2024-03-31 $13
2023-12-31 $72
2023-09-30 $32
2023-06-30 $7
2023-03-31 $-4
2022-12-31 $37
2022-09-30 $-5
2022-06-30 $-2
2022-03-31 $-6
2021-12-31 $30
2021-09-30 $9
2021-06-30 $-8
2021-03-31 $-15
2020-12-31 $-403
2020-09-30 $9
2020-06-30 $14
2020-03-31 $-3
2019-12-31 $2
2019-09-30 $-1
2019-06-30 $-5
2019-03-31 $-5
2018-12-31 $-2
2018-09-30 $-0
2018-06-30 $-5
2018-03-31 $-8
2017-12-31 $-1
2017-09-30 $-10
2017-06-30 $-12
2017-03-31 $-12
2016-12-31 $-10
2016-09-30 $-10
2016-06-30 $-13
2016-03-31 $-13
2015-12-31 $-13
2015-09-30 $-11
2015-06-30 $-15
2015-03-31 $-12
2014-12-31 $-6
2014-09-30 $-3
2014-06-30 $-2
2014-03-31 $-2
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $1.625B $2.602B
Teladoc Health, Inc. provides virtual access to high-quality care and expertise with a portfolio of services and solutions, covering medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company combines the latest in data and analytics with an award-winning user experience through a highly flexible technology platform. The company provides access to healthcare through its portfolio of five consumer brands 24 hours a day, seven days a week and 365 days a year. Its solutions are delivered with an approximate median response time of less than ten minutes in the United States for general medical inquiries from the time a member requests a general medical telehealth visit to the time they consult with a Teladoc Health network provider.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $84.874B 10.53
Cencora (COR) United States $44.008B 16.55
DiDi Global (DIDIY) China $22.650B 0.00
Natera (NTRA) United States $21.372B 0.00
ICON (ICLR) Ireland $17.119B 15.25
Viatris (VTRS) United States $14.944B 4.60
Avantor (AVTR) United States $14.436B 21.64
Revvity (RVTY) United States $13.699B 23.80
BioMerieux (BMXMF) France $12.615B 0.00
CochLear (CHEOY) Australia $11.851B 0.00
Solventum (SOLV) United States $11.545B 0.00
Doximity (DOCS) United States $10.796B 63.55
Medpace Holdings (MEDP) United States $10.483B 29.53
Charles River Laboratories (CRL) United States $9.500B 18.36
HealthEquity (HQY) United States $8.229B 41.28
Sonic Healthcare (SKHHY) Australia $8.181B 0.00
Bausch + Lomb (BLCO) Canada $6.339B 29.51
Amplifon S.p.A (AMFPF) Italy $5.864B 29.89
Organon (OGN) United States $3.755B 3.79
Sotera Health (SHC) United States $3.750B 20.06
BrightSpring Health Services (BTSG) United States $3.007B 63.96
Surgery Partners (SGRY) United States $2.697B 30.75
Concentras Parent (CON) United States $2.551B 0.00
Ardent Health Partners (ARDT) United States $2.285B 0.00
GeneDx Holdings (WGS) United States $2.126B 0.00
Premier (PINC) United States $2.091B 10.88
Alignment Healthcare (ALHC) United States $2.034B 0.00
PACS (PACS) United States $1.983B 0.00
GoodRx Holdings (GDRX) United States $1.692B 44.40
Ryman Healthcare (RYHTY) New Zealand $1.651B 0.00
Progyny (PGNY) United States $1.221B 24.72
Pediatrix Medical (MD) United States $1.210B 11.84
Embecta (EMBC) United States $1.176B 8.22
Establishment Labs Holdings (ESTA) $1.120B 0.00
CareDx (CDNA) United States $1.105B 0.00
AMN Healthcare Services Inc (AMN) United States $0.873B 5.91
Agilon Health (AGL) United States $0.812B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 0.00
SBC Medicals (SBC) United States $0.622B 0.00
InnovAge Holding (INNV) United States $0.568B 0.00
Auna S.A (AUNA) Luxembourg $0.501B 0.00
DocGo (DCGO) United States $0.460B 17.35
Sonida Senior Living (SNDA) United States $0.452B 0.00
Enhabit (EHAB) United States $0.385B 33.26
Sera Prognostics (SERA) United States $0.297B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.272B 0.00
Biodesix (BDSX) United States $0.228B 0.00
LifeMD (LFMD) United States $0.218B 0.00
Beauty Health (SKIN) United States $0.181B 0.00
Nutex Health (NUTX) United States $0.160B 0.00
ModivCare (MODV) United States $0.159B 8.63
MultiPlan (MPLN) United States $0.097B 0.00
Ascend Wellness Holdings (AAWH) United States $0.092B 0.00
So-Young (SY) China $0.091B 15.40
IceCure Medical (ICCM) Israel $0.051B 0.00
Singular Genomics Systems (OMIC) United States $0.049B 0.00
OncoCyte (OCX) United States $0.037B 0.00
NeueHealth (NEUE) United States $0.032B 0.84
Pheton Holdings (PTHL) China $0.027B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.023B 0.00
Co-Diagnostics (CODX) United States $0.023B 0.00
Oncology Institute (TOI) United States $0.016B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
KindlyMD (KDLY) United States $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
Aclarion (ACON) United States $0.001B 0.00
Cano Health (CANOQ) United States $0.001B 0.00